Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "We expect PDS will fund its operations through licensing revenue."
Reply New Message
Back To Forum List View
"We expect PDS will fund its operations through licensing revenue."
13
gcduck
Oct 17, 2011 04:56PM

I would rather have seen "fully anticipate" rather than "expect".

Even better, "Based on expert forensic accounting analysis of PDS and of its associated pipeline of potential licenses, we fully anticipate that PDS will fund its operations through licensing revenue."

1 Recommendations
Re: "We expect PDS will fund its operations through licensing revenue."
6
MagnusBuchs
Oct 17, 2011 05:11PM
Re: "We expect PDS will fund its operations through licensing revenue."

mikesmark
Oct 17, 2011 05:39PM
Re: "We expect PDS will fund its operations through licensing revenue."
6
jldmt
Oct 17, 2011 05:53PM
Re: "We expect PDS will fund its operations through licensing revenue."

shboomer
Oct 17, 2011 06:12PM
Icon president Re: "We expect PDS will fund its operations through licensing revenue."
4
optymystic
Oct 17, 2011 06:40PM
Re: "We expect PDS will fund its operations through licensing revenue."

MagnusBuchs
Oct 18, 2011 09:53AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply